GS0051: Pharmaceuticals for the treatment of cancer, immunological-inflammatory conditions, tissue repair, eye diseases, and cardiovascular disease
GS0421: Scientific research and development in the fields of cancer, immunological-inflammatory conditions, tissue repair, eye diseases, cardiovascular disease, biology, laboratory testing, biotechnology, biochemistry, and medicine; research and product development services for others in the fields of cancer, immunological-inflammatory conditions, tissue repair, eye diseases, cardiovascular disease, biology, laboratory testing, biotechnology, biochemistry, and medicine; medical and scientific research for the detection of cancer, immunological-inflammatory conditions, tissue repair, eye diseases, and cardiovascular disease; providing information on the subject of scientific research in the fields of cancer, immunological-inflammatory conditions, tissue repair, eye diseases, cardiovascular disease, biology, laboratory testing, biotechnology, biochemistry, and medicine
Case File Event Statements
10/1/2020 - 4 years ago
8 - ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPONDType:MAB2
10/1/2020 - 4 years ago
7 - ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEType:ABN2
3/17/2020 - 4 years ago
6 - NOTIFICATION OF NON-FINAL ACTION E-MAILEDType:GNRN
3/17/2020 - 4 years ago
5 - NON-FINAL ACTION E-MAILEDType:GNRT
3/17/2020 - 4 years ago
4 - NON-FINAL ACTION WRITTENType:CNRT
3/16/2020 - 4 years ago
3 - ASSIGNED TO EXAMINERType:DOCK
12/20/2019 - 5 years ago
2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAMType:NWOS